High density lipoprotein particle size restriction in apolipoprotein A- I(Milano) transgenic mice

Journal of Lipid Research

Volumn 38, Issue 11, 1997, Pages 2314-2321

  Bielicki, John K ^a   Forte, Trudy M ^a   McCall, Mark R ^a   Stoltzfus, Lori J ^a   Chiesa, Giulia ^b   Sirtori, Cesare R ^b   Franceschini, Guido ^b   Rubin, Edward M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Apolipoprotein A I(Milano); HDL size restriction; LCAT activity; Transgenic mice

Indexed keywords

APOLIPOPROTEIN A1;

ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; CENTRIFUGATION, DENSITY GRADIENT; CHOLESTEROL; CHOLESTEROL ESTERS; DIMERIZATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; LIPOPROTEINS, HDL; MICE; MICE, TRANSGENIC; MUTAGENESIS, SITE-DIRECTED; PARTICLE SIZE; PHENOTYPE; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE;

EID: 0030691945     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Gordon, T., W. P. Castelli, M. C. Hjortland, W. B. Kannel, and T. R. Dawber. 1977. High density lipoprotein as a protective factor against coronary heart disease. Am. J. Med. 62: 707-714.
2. Rifkind, B. M. 1990. High-density lipoprotein cholesterol and coronary artery disease: survey of the evidence. Am. J. Cardiol. 66: 3A-6A.
3. Wilson, P. W. F. 1990. High-density lipoprotein, low-density lipoprotein and coronary artery disease. Am. J. Cardiol. 66: 7A-10A.
4. Glomset, J. A. 1968. The plasma lecithin: cholesterol acyltransferase reaction. J. Lipid Res. 9: 155-167.
5. Rothblat, G. H., and M. C. Phillips. 1991. Cholesterol efflux from arterial wall cells. Curr. Opin. Lipidol. 2: 288-294.
6. Tall, A. R. 1990. Plasma high density lipoproteins: metabolism and relationship to atherogenesis. J. Clin. Invest. 86: 379-384.
7. Assmann, G., A. von Eckardstein, and H. Funke. 1993. High density lipoproteins, reverse transport of cholesterol, and coronary artery disease: insights from mutations. Circulation. 87[suppl III]: 28-34.
8. Matsunaga, T., Y. Hiasa, H. Yanagi, T. Maeda, N. Hattori, K. Yamakawa, Y. Yamanouchi, I. Tanaka, T. Obara, and H. Hamaguchi. Apolipoprotein A-I deficiency due to a codon 84 nonsense mutation of the apolipoprotein A-I gene. Proc. Natl. Acad. Sci. USA. 88: 2793-2797.
9. Funke, H., A. von Eckardstein, P. H. Pritchard, M. Karas, J. J. Albers, and G. Assmann. 1991. A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin : cholesterol acyltransferase deficiency, and corneal opacities. J. Clin. Invest. 87: 371-376.
10. Weisgraber, K. H., T. P. Bersot, R. W. Mahley, G. Franceschini, and C. R. Sirtori. 1980. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins. J. Clin. Invest. 66: 901-907.
11. Franceschini, G., C. R. Sirtori, A. Capurso, K. H. Weisgraber, and R. W. Mahley. 1980. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. J. Clin. Invest. 66: 892-899.
12. Milano variant. J. Biol. Chem. 257: 9926-9930.
13. Milano: correlation between high density lipoprotein subclass distribution and triglyceridemia. Arteriosclerosis. 7: 426-435.
14. Milano: partial lecithin: cholesterol acyltransferase deficiency due to low levels of a functional enzyme. Biochim. Biophys. Acta. 1043: 1-6.
15. Milano: disulfide-linked dimers increase high density lipoprotein stability and hinder particle interconversion in carrier plasma. J. Biol. Chem. 265: 12224-12231.
16. Milano has reduced capacity, compared to wild-type apolipoprotein A-I, to recruit membrane cholesterol. Arterioscler. Thromb. Vasc. Biol. In press.
17. Schultz, J. R., J. G. Verstuyft, E. L. Gong, A. V. Nichols, and E. M. Rubin. 1993. Protein composition determines anti-atherogenic properties of HDL in transgenic mice. Nature. 365: 762-764.
18. Rubin, E. M., B. Y. Ishida, S. M. Clift, and R. M. Krauss. 1991. Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses. Proc. Natl. Acad. Sci. USA. 88: 434-438.
19. Steele, B. W., D. E. Koehler, and M. M. Azar. 1976. Enzymatic determination of cholesterol in high-density lipoprotein fractions prepared by precipitation techniques. Clin. Chem. 22: 98-191.
20. Lindgren, F. T., L. C. Jensen, and F. T. Hatch. 1972. Blood Lipids and Lipoproteins: Quantitation, Composition, and Metabolism. Wiley-Interscience, NY. 181-274.
21. Markwell, M. K., S. M. Haas, L. L. Bieber, and N. E. Tolbert. 1978. A modification of the Lowry protein proce-dure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87: 206-210.
22. Chen, P. S., T. Y. Toribara, and H. Warner. 1956. Microdetermination of phosphorus. Anal. Chem. 28: 1756-1759.
23. Sale, F. O., S. Marchesini, P. H. Fishman, and B. Berra. 1984. A sensitive enzymatic assay for determination of cholesterol in lipid extracts. Anal. Biochem. 142: 347-350.
24. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227: 680-685.
25. Nichols, A. V., R. M. Krauss, and T. A. Musliner. 1986. Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol. 128: 417-431.
26. Chen, C., and J. J. Albers. 1982. Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin : cholesterol acyltransferase activity. J. Lipid Res. 23: 680-691.
27. Milano variant. Biochim. Biophys. Acta. 960: 73-82.
28. Vaisman, B. L., H. Klein, M. Rouis, A. M. Berard, M. R. Kindt, G. D. Talley, S. M. Meyn, R. F. Hoyt, S. M. Marcovina, J. J. Albers, J. M. Hoeg, H. B. Brewer, and S. Fojo. 1995. Overexpress.sion of human lecithin : cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice. J. Biol. Chem. 270: 12269-12275.
29. Albers, J. J., R. O. Bergelin, J. L. Adolphson, and P. W. Wahl. 1982. Population-based reference values for lecithin: cholesterol acyltransferase (LGAT). Atherosclerosis. 43: 369-379.
30. Parks, J. S., H. Li, A. K. Gebre, T. L. Smith, and N. Maeda. 1995. Effect of apolipoprotein A-I deficiency on lecithin: cholesterol acyltransferase activation in mouse plasma. J. Lipid Res. 36: 349-355.